Study of recombinant human interleukin-12 for treatment of complications after radiotherapy for tumor patients

doi:10.5306/wjco.v8.i2.158

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 2

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9851)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-4) series.

Item

Count

PDF

436

WORD

268

HTML

3515

Figures (1-4)

144

Tables (1-4)

155

Sum=4518

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

814

Download

2599

Sum=3413

Publishing Process of This Article

Item

Count

Browse

677

Download

1243

Sum=1920

Apr 10, 2017 (publication date) through May 3, 2024

Times Cited of This Article

Times Cited (7)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Trials Study

World J Clin Oncol. Apr 10, 2017; 8(2): 158-167
Published online Apr 10, 2017. doi: 10.5306/wjco.v8.i2.158

Table 3 Results of objective evaluation for the treatment group and the control group

Group	n	CR	%	PR	%	MR	%	PD	%
Treatment	50	12	24^a	30	60	5^a	10^a	3^a	6^a
Control	10	5	10	25	50	10	20	10	20

Compared with the control group,

^aP < 0.05. CR: Complete remission; PR: Partial remission.

Citation: Guo N, Wang WQ, Gong XJ, Gao L, Yang LR, Yu WN, Shen HY, Wan LQ, Jia XF, Wang YS, Zhao Y. Study of recombinant human interleukin-12 for treatment of complications after radiotherapy for tumor patients. World J Clin Oncol 2017; 8(2): 158-167
URL: https://www.wjgnet.com/2218-4333/full/v8/i2/158.htm
DOI: https://dx.doi.org/10.5306/wjco.v8.i2.158